{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:29Z","timestamp":1793830889174,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jsbmb.2024.106621","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:31:45Z","timestamp":1726493505000},"page":"106621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis"],"prefix":"10.1016","volume":"245","author":[{"given":"Silke","family":"Matysik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Elger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Huss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kandulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke Christian","family":"Tews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn's disease","volume":"64","author":"Gajendran","year":"2018","journal-title":"Dis. Mon."},{"issue":"12","key":"10.1016\/j.jsbmb.2024.106621_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A comprehensive review and update on ulcerative colitis","volume":"65","author":"Gajendran","year":"2019","journal-title":"Dis. Mon."},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med Life"},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/00365521.2010.539253","article-title":"Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy","volume":"46","author":"Lonnkvist","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"issue":"7-8","key":"10.1016\/j.jsbmb.2024.106621_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00508-009-1150-6","article-title":"Cholesterol metabolism in active Crohn's disease","volume":"121","author":"Hrabovsky","year":"2009","journal-title":"Wien. Klin. Woche"},{"key":"10.1016\/j.jsbmb.2024.106621_bib6","unstructured":"Feingold K.R., Grunfeld C.: The Effect of Inflammation and Infection on Lipids and Lipoproteins. In: Endotext. edn. Edited by{C} Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K., Hofland J. et al.{C} South Dartmouth (MA); 2000."},{"issue":"23","key":"10.1016\/j.jsbmb.2024.106621_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/foods12234308","article-title":"Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms","volume":"12","author":"Deng","year":"2023","journal-title":"Foods"},{"issue":"5","key":"10.1016\/j.jsbmb.2024.106621_bib8","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302453","article-title":"Cholesterol and COVID-19-therapeutic opportunities at the host\/virus interface during cell entry","volume":"7","author":"Grewal","year":"2024","journal-title":"Life Sci. Alliance"},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12944-023-01971-4","article-title":"Altered fecal bile acid composition in active ulcerative colitis","volume":"22","author":"Sommersberger","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"5","key":"10.1016\/j.jsbmb.2024.106621_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050901","article-title":"Bile acids: key players in inflammatory bowel diseases?","volume":"11","author":"Kriaa","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MOL.0000000000000473","article-title":"Transintestinal cholesterol excretion in humans","volume":"29","author":"Reeskamp","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.jsbmb.2024.106621_bib12","first-page":"1697","article-title":"Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis, a high-risk group for development of colon cancer","volume":"37","author":"Reddy","year":"1977","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.P031021","article-title":"Plasma plant sterols serve as poor markers of cholesterol absorption in man","volume":"54","author":"Jakulj","year":"2013","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.jsbmb.2024.106621_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-031-43883-7_12","article-title":"Implication of oxysterols and phytosterols in aging and human diseases","volume":"1440","author":"Vigne","year":"2024","journal-title":"Adv. Exp. Med Biol."},{"issue":"Pt B)","key":"10.1016\/j.jsbmb.2024.106621_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chemphyslip.2017.08.003","article-title":"Oxysterols and phytosterols in human health","volume":"207","author":"Massaad","year":"2017","journal-title":"Chem. Phys. Lipids"},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ecco-jcc\/jjy157","article-title":"Colitis alters oxysterol metabolism and is affected by 4beta-hydroxycholesterol administration","volume":"13","author":"Guillemot-Legris","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jsbmb.2024.106621_bib17","article-title":"A gradient of intestinal inflammation in primary sclerosing cholangitis","author":"Wittek","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.dld.2011.07.020","article-title":"Serum lipids in primary sclerosing cholangitis","volume":"44","author":"Sinakos","year":"2012","journal-title":"Dig. Liver Dis.: Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/liv.12680","article-title":"Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"35","author":"Bell","year":"2015","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jsbmb.2024.106621_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2019_226","article-title":"Chenodeoxycholic acid: an update on its therapeutic applications","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb. Exp. Pharm."},{"issue":"3","key":"10.1016\/j.jsbmb.2024.106621_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lipd.12033","article-title":"Noncholesterol sterols as surrogate markers in patients with severe alcoholic hepatitis","volume":"53","author":"Sahlman","year":"2018","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1172\/JCI115034","article-title":"Influence of age on the metabolism of plasma low density lipoproteins in healthy males","volume":"87","author":"Ericsson","year":"1991","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib23","article-title":"Bioactive lipids in inflammatory bowel diseases - from pathophysiological alterations to therapeutic opportunities","volume":"1866","author":"Alhouayek","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib24","first-page":"124","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence","volume":"32","author":"Mertz","year":"2019","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jsbmb.2024.106621_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1055\/a-1015-7048","article-title":"Aktualisierung der S3-Leitlinie Colitis ulcerosa 2019","volume":"57","author":"Kucharzik","year":"2019","journal-title":"Z. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jsbmb.2024.106621_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects","volume":"13","author":"Sturm","year":"2019","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.jsbmb.2024.106621_bib28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL CPGosc: EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12291-010-0095-x","article-title":"Serum lipid profile: fasting or non-fasting?","volume":"26","author":"Nigam","year":"2011","journal-title":"Indian J. Clin. Biochem"},{"key":"10.1016\/j.jsbmb.2024.106621_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106361","article-title":"A targeted GC-MS\/MS approach for the determination of eight sterols in microgreen and mature plant material","volume":"232","author":"Castellaneta","year":"2023","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2024.106621_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2019.03.014","article-title":"A comprehensive method to determine sterol species in human faeces by GC-triple quadrupole MS","volume":"190","author":"Kunz","year":"2019","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2024.106621_bib32","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2012.189605","article-title":"Gas chromatography-tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors","volume":"58","author":"Matysik","year":"2012","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.jsbmb.2024.106621_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.jsbmb.2024.106621_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100050","article-title":"Accurate quantification of lipid species affected by isobaric overlap in Fourier-Transform mass spectrometry","author":"Horing","year":"2021","journal-title":"J. Lipid Res"},{"issue":"16","key":"10.1016\/j.jsbmb.2024.106621_bib35","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1021\/acs.analchem.0c02408","article-title":"Correction of isobaric overlap resulting from sodiated ions in lipidomics","volume":"92","author":"Horing","year":"2020","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jsbmb.2024.106621_bib36","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/acs.analchem.8b05013","article-title":"Quantification of cholesterol and cholesteryl ester by direct flow injection high-resolution fourier transform mass spectrometry utilizing species-specific response factors","volume":"91","author":"Horing","year":"2019","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib37","first-page":"72","article-title":"Review article on parametric and nonparametric test","volume":"10","author":"Sharma","year":"2024","journal-title":"World J. Pharm. Med. Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2024.106621_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1472-765X.1995.tb00410.x","article-title":"Hypocholesterolemic effect of Eubacterium coprostanoligenes ATCC 51222 in rabbits","volume":"20","author":"Li","year":"1995","journal-title":"Lett. Appl. Microbiol"},{"key":"10.1016\/j.jsbmb.2024.106621_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021924","article-title":"Bile acids as inflammatory mediators and modulators of intestinal permeability","volume":"13","author":"Calzadilla","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jsbmb.2024.106621_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00616-22","article-title":"Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission","volume":"10","author":"Pisani","year":"2022","journal-title":"Microbiol Spectr."},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/00365521.2011.615859","article-title":"Major alterations in metabolic activity of intestinal microflora in Crohn's disease","volume":"47","author":"Benno","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.jsbmb.2024.106621_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066074","article-title":"Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform","volume":"8","author":"Midtvedt","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jsbmb.2024.106621_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107697","article-title":"High-fat diet impact on intestinal cholesterol conversion by the microbiota and serum cholesterol levels","volume":"26","author":"Bubeck","year":"2023","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.jsbmb.2024.106621_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9091881","article-title":"Cholesterol-to-coprostanol conversion by the gut microbiota: what we know, suspect, and ignore","volume":"9","author":"Juste","year":"2021","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.jsbmb.2024.106621_bib46","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.metabol.2006.03.006","article-title":"Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system","volume":"55","author":"Ripolles Piquer","year":"2006","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib47","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.clnu.2018.08.012","article-title":"Impact of colonic fermentation on sterols after the intake of a plant sterol-enriched beverage: a randomized, double-blind crossover trial","volume":"38","author":"Cuevas-Tena","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jsbmb.2024.106621_bib48","article-title":"Phytosterols: from preclinical evidence to potential clinical applications","volume":"11","author":"Salehi","year":"2020","journal-title":"Front Pharm."},{"issue":"9","key":"10.1016\/j.jsbmb.2024.106621_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108112","article-title":"Antiinflammatory effect of phytosterols in experimental murine colitis model: prevention, induction, remission study","volume":"9","author":"Aldini","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/foods8040114","article-title":"Effect of a milk-based fruit beverage enriched with plant sterols and\/or galactooligosaccharides in a murine chronic colitis model","volume":"8","author":"Lopez-Garcia","year":"2019","journal-title":"Foods"},{"issue":"6","key":"10.1016\/j.jsbmb.2024.106621_bib51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0168-8278(03)00194-6","article-title":"Biliary cholesterol secretion: more lessons from plants?","volume":"38","author":"Stieger","year":"2003","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jsbmb.2024.106621_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12090846","article-title":"Fecal bile acids and neutral sterols are associated with latent microbial subgroups in the human gut","volume":"12","author":"Breuninger","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.jsbmb.2024.106621_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MED.0b013e3283292312","article-title":"The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease","volume":"16","author":"Sabeva","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0168-8278(96)80165-6","article-title":"The metabolism of cholestanol in primary biliary cirrhosis","volume":"24","author":"Gylling","year":"1996","journal-title":"J. Hepatol."},{"issue":"206","key":"10.1016\/j.jsbmb.2024.106621_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006898","article-title":"Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease","volume":"5","author":"El Kasmi","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.jsbmb.2024.106621_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113648","article-title":"7-Ketocholesterol and 7beta-hydroxycholesterol: In vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity.","volume":"173","author":"Vejux","year":"2020","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.jsbmb.2024.106621_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2006.09.026","article-title":"Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers","volume":"194","author":"Burkard","year":"2007","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.5477","article-title":"Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling","volume":"251","author":"Houben","year":"2020","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.jsbmb.2024.106621_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2011.01.003","article-title":"27-Hydroxycholesterol: the first identified endogenous SERM","volume":"22","author":"Umetani","year":"2011","journal-title":"Trends Endocrinol. Metab."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076024001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076024001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T17:05:43Z","timestamp":1732813543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076024001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":59,"alternative-id":["S0960076024001699"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106621","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106621"}}